Transglucosidase improves the gut microbiota profile of type 2 diabetes mellitus patients: a randomized double-blind, placebo-controlled study
Open Access
- 8 May 2013
- journal article
- research article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 81
Abstract
Recently, the relationship between gut microbiota and obesity has been highlighted. The present randomized, double-blind, placebo-controlled study aimed to evaluate the efficacy of transglucosidase (TGD) in modulating blood glucose levels and body weight gain in patients with type 2 diabetes mellitus (T2DM) and to clarify the underlying mechanism by analyzing the gut microbiota of T2DM patients.Keywords
This publication has 19 references indexed in Scilit:
- Cloning, Nucleotide Sequencing and Bioinformatics Study of NcSRS2 Gene, an Immunogen from Iranian Isolate of Neospora caninum2013
- Effects of transglucosidase on diabetes, cardiovascular risk factors and hepatic biomarkers in patients with type 2 diabetes: a 12‐week, randomized, double‐blind, placebo‐controlled trialDiabetes, Obesity and Metabolism, 2011
- A Novel Strategy in Production of Oligosaccharides in Digestive Tract: Prevention of Postprandial Hyperglycemia and HyperinsulinemiaJournal of Clinical Biochemistry and Nutrition, 2007
- Human gut microbes associated with obesityNature, 2006
- An obesity-associated gut microbiome with increased capacity for energy harvestNature, 2006
- Obesity alters gut microbial ecologyProceedings of the National Academy of Sciences, 2005
- The gut microbiota as an environmental factor that regulates fat storageProceedings of the National Academy of Sciences, 2004
- Development of a data-based short food frequency questionnaire for assessing nutrient intake by middle-aged Japanese.2004
- Isolation of genomic DNAs from plants, fungi and bacteria using benzyl chlorideNucleic Acids Research, 1993
- UNABSORBABLE CARBOHYDRATES AND DIABETES: DECREASED POST-PRANDIAL HYPERGLYCÆMIAThe Lancet, 1976